Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or... – Modification of viruses
Patent
1987-04-30
1990-04-17
Wiseman, Thomas G.
Chemistry: molecular biology and microbiology
Treatment of micro-organisms or enzymes with electrical or...
Modification of viruses
536 27, 435320, 4352523, 43525235, 435886, 935 29, 935 56, C12N 120, C12N 700, C12P 2100, C12R 1465
Patent
active
049180150
ABSTRACT:
S. ghanaensis DSM 2932 is resistant to gentamicin at up to 20 .mu.g/ml. Total digestion of the genomic DNA with BglII, incorporation of the restriction fragments into a suitable plasmid, and selection using gentamicin results in gentamicin-resistant clones which contain a 7 kb fragment with the gentamicin-resistance gene. The plasmid pPH1JI likewise contains a gentamicin-resistance gene located on a 2.3 kb HindIII-BamHI fragment. These genes are suitable as markers, in particular for Streptomycetes vectors.
REFERENCES:
patent: 4332900 (1982-06-01), Manis et al.
Hirsch & Beringer, A Physical Map of pPH1JI and pJB4JI, Plasmid 12, 139-141 (1984).
Vieira & Messing, the pUC Plasmids an M13mp 7-Derived System for Insertion Mutagenesis and Sequencing with Synthetic Universal Primers, Gene, 19 pp. 259-268 (1982).
Yangsch-Perron et al., Improved M13 phage Cloning Vectors and Host Strains: Nucleotide Sequences of the M13mp18 and pUC19 Vectors, Gene, 33 (1985), 103-119.
Muth Gunter
Puhler Alfred
Wohlleben Wolfgang
Hoechst Aktiengesellschaft
Nolan S. L.
Wiseman Thomas G.
LandOfFree
Gentamicin-resistance genes and their use as markers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gentamicin-resistance genes and their use as markers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gentamicin-resistance genes and their use as markers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1052465